Advertisement

Topics

Eiger expands deal with Merck, provides lonafarnib to Progeria

06:04 EDT 17 May 2018 | SmartBrief

Eiger BioPharmaceuticals and Merck will expand their licensing agreement to include Eiger's rights to develop the Hutchinson- -More

Original Article: Eiger expands deal with Merck, provides lonafarnib to Progeria

NEXT ARTICLE

More From BioPortfolio on "Eiger expands deal with Merck, provides lonafarnib to Progeria"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...